CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Ovulation Induction

Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum.

Subtype terms (1)

More specific conditions that are subtypes of Ovulation Induction in the MeSH hierarchy.

  • Superovulation

Drugs by status

Phase 4 trials (17)

  • follitropin alfa
  • leuprolide
  • ganirelix
  • urofollitropin
  • myoinositol
  • follitropin beta
  • Anti-thymocyte Globulin (Rabbit)
  • medroxyprogesterone
  • menopausal gonadotropin
  • basiliximab
  • letrozole
  • clomifene
  • lutropin alpha
  • dinoprostone
  • buserelin
  • corifollitropin alfa
  • human choriogonadotropin alfa

Phase 3 trials (3)

  • vitamin d3
  • oxytocin
  • calcium

Phase 2 trials (7)

  • as900672
  • certolizumab pegol
  • ethinyl estradiol
  • desogestrel
  • Menotropin
  • ql1706
  • ql-1706

Other trials (7)

  • dehydroepiandrosterone
  • dydrogesterone
  • cetrorelix
  • daunorubicin
  • phytoestrogens
  • triptorelin
  • etoposide

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.